Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial Strategies for the Induction of Immunogenic Cell Death
Lucillia Bezu, Ligia C. Gomes-de-Silva, Heleen Dewitte, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 378

Showing 26-50 of 378 citing articles:

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
Gabrielle Planes-Laine, Philippe Rochigneux, François Bertucci, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 193
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 644-654
Open Access | Times Cited: 190
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy
Shenwu Zhang, Jing Wang, Zhiqiang Kong, et al.
Biomaterials (2022) Vol. 282, pp. 121433-121433
Closed Access | Times Cited: 188
Hyperthermia and smart drug delivery systems for solid tumor therapy
Ann L.B. Seynhaeve, Mohamadreza Amin, Dieter Haemmerich, et al.
Advanced Drug Delivery Reviews (2020) Vol. 163-164, pp. 125-144
Open Access | Times Cited: 183
Origin and Consequences of Necroinflammation
Maysa Sarhan, W. Land, Wulf Tonnus, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 727-780
Open Access | Times Cited: 179
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Alfonso Serrano del Valle, Alberto Anel, Javier Naval, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 177
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Alessandro Leonetti, Birgit M. M. Wever, Giulia Mazzaschi, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100644-100644
Closed Access | Times Cited: 176
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
Magalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
OncoImmunology (2018) Vol. 7, Iss. 6
Open Access | Times Cited: 174
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 124-138
Open Access | Times Cited: 165
Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy
Shibin Qu, Tejaswi Worlikar, Amy E. Felsted, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000200-e000200
Open Access | Times Cited: 158
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
Miao Yu, Gang Guo, Lei Huang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
Jordi Remón, Francesco Passiglia, Myung‐Ju Ahn, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 6, pp. 914-947
Open Access | Times Cited: 140
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Zhiqi Zhang, Xiaoxuan Xu, Jiawei Du, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 35
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
Nicole Rufo, Abhishek D. Garg, Patrizia Agostinis
Trends in cancer (2017) Vol. 3, Iss. 9, pp. 643-658
Open Access | Times Cited: 166
The immune mechanisms of abscopal effect in radiation therapy
G. Daniel Grass, Niveditha Krishna, Sungjune Kim
Current Problems in Cancer (2015) Vol. 40, Iss. 1, pp. 10-24
Closed Access | Times Cited: 164
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
Charlotte S. Lo, Sanaz Sanii, David R. Kroeger, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 4, pp. 925-934
Open Access | Times Cited: 153
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
Jitka Fučíková, Irena Moserová, Linda Urbanová, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 152
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer
Cancer Immunology Research (2016) Vol. 4, Iss. 11, pp. 895-902
Closed Access | Times Cited: 152
Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?
Hans‐Peter Gerber, Puja Sapra, Frank Loganzo, et al.
Biochemical Pharmacology (2015) Vol. 102, pp. 1-6
Closed Access | Times Cited: 151
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
Abdi Ghaffari, Nichole Peterson, Kasra Khalaj, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 4, pp. 440-449
Open Access | Times Cited: 144
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma
Steffen Böhm, Anne Montfort, Oliver M.T. Pearce, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 12, pp. 3025-3036
Open Access | Times Cited: 139
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
Chanyoung Song, Hathaichanok Phuengkham, Young Seob Kim, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 139
Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone
Shiyao Zhou, Qi Shang, Ningning Wang, et al.
Journal of Controlled Release (2020) Vol. 328, pp. 617-630
Closed Access | Times Cited: 139
The Diversification of Cell Death and Immunity: Memento Mori
Arnaud J. Legrand, Maria Konstantinou, E. Goode, et al.
Molecular Cell (2019) Vol. 76, Iss. 2, pp. 232-242
Open Access | Times Cited: 138

Scroll to top